Theriva Biologics, Inc.
Develops systemic oncolytic virus therapies to selectively destroy difficult-to-treat cancers.
TOVX | US
Overview
Corporate Details
- ISIN(s):
- US87164U5083 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 9605 MEDICAL CENTER DRIVE, 20850 ROCKVILLE
- Website:
- https://therivabio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Theriva Biologics, Inc. is a clinical-stage immuno-oncology company developing a new class of oncolytic virus therapeutics. The company's platform engineers viruses for systemic delivery, designed to overcome the protective barriers of solid tumors and selectively destroy cancer cells. These developmental therapies are intended to treat a broad range of difficult-to-treat cancers and have the potential to be combined with or enhance current standard-of-care treatments. Theriva's lead candidates are being evaluated in clinical trials to address diseases in areas of high unmet medical need.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Theriva Biologics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theriva Biologics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theriva Biologics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
